Lu, Ju http://orcid.org/0000-0002-7010-3799
Tjia, Michelle
Mullen, Brian http://orcid.org/0000-0002-1340-8692
Cao, Bing
Lukasiewicz, Kacper
Shah-Morales, Sajita
Weiser, Sydney http://orcid.org/0000-0003-2298-4170
Cameron, Lindsay P.
Olson, David E. http://orcid.org/0000-0002-4517-0543
Chen, Lu
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH109475, R01MH104227, T32MH112507, R01MH091193)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS104950, R01NS115660)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD101266, R01HD084215)
Max-Planck-Gesellschaft (Max Planck Fellowship)
SU | School of Medicine, Stanford University (Stanford Dean’s Postdoctoral Fellowship)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM128997)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Article History
Received: 7 January 2021
Revised: 28 April 2021
Accepted: 5 May 2021
First Online: 25 May 2021
Compliance with ethical standards
:
: DEO is the president and chief scientific officer of Delix Therapeutics, Inc. All other authors have no competing interest.